Oversubscribed GBP2.5M seed round led by Ahren Innovation Capital -- Strategic collaboration with o2h to progress drug discovery programme CAMBRIDGE, England--(BUSINESS WIRE)--January 12, 2026-- ...

Join us for a webinar on how advances in target-based drug discovery are reshaping therapeutic design. We’ll explore ...

Quantum systems can simulate molecular interactions at a level of fidelity that classical computers cannot achieve. They can ...

SAN DIEGO--(BUSINESS WIRE)--Sapient, a leader in multi-omics data generation for biomarker discovery and clinical insight delivery, has launched the next generation of its multi-omics and real-world ...

AI across the pharmaceutical ecosystem. The Illumina Billion Cell Atlas is the first tranche of its program to build a 5 billion cell atlas over three years, and will be the most comprehensive map of ...

Large language models (LLMs) can be broadly applied across multiple key stages in drug development: (1) Target identification and drug screening. Llama-Gram, GPCR LLM, and ProtChat systems effectively ...

Zhongyao Ma, PhD, holds a bachelor’s degree in biology from Shanghai Jiao Tong University and a PhD in genetics and developmental biology from the University of Georgia, U.S. His research focused on ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

LOS ANGELES, CA / ACCESS Newswire / August 6, 2025 / Today MAX BioPharma, Inc. (www.maxbiopharma.com) and Revilico, Inc. (www.revilico.bio) announced their collaboration in studying the mechanisms of ...

Target validation will be conducted through partnership with J. Craig Venter Institute (JCVI), a world-leading institution in genomics research and innovation GAITHERSBURG, Md., Oct. 05, 2023 (GLOBE ...